Expression of infectious pancreatic necrosis virus (IPNV) VP2-VP3 fusion protein in Lactobacillus casei and immunogenicity in rainbow trouts (Q45360524)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 January 2012

Language	Label	Description	Also known as
English	Expression of infectious pancreatic necrosis virus (IPNV) VP2-VP3 fusion protein in Lactobacillus casei and immunogenicity in rainbow trouts	scientific article published on 9 January 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Expression of infectious pancreatic necrosis virus (IPNV) VP2-VP3 fusion protein in Lactobacillus casei and immunogenicity in rainbow trouts (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Lacticaseibacillus casei

object named as

Lactobacillus casei

1 reference

based on heuristic

inferred from title

author name string

Li-Li Zhao

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Min Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Jun-Wei Ge

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Xin-Yuan Qiao

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Yi-Jing Li

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Di-Qiu Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

9 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1823-1829

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Active residues and viral substrate cleavage sites of the protease of the birnavirus infectious pancreatic necrosis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

The nucleotide sequence of infectious pancreatic necrosis virus (IPNV) dsRNA segment A reveals one large ORF encoding a precursor polyprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Immunogenicity properties of authentic and heterologously synthesized structural protein VP2 of infectious pancreatic necrosis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Evidence of a major neutralizable conformational epitope region on VP2 of infectious pancreatic necrosis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Isolation in cell culture and detection by PCR-based technology of IPNV-like virus from leucocytes of carrier turbot, Scophthalmus maximus (L.).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Infectious pancreatic necrosis virus establishes an asymptomatic carrier state in kidney leucocytes of juvenile Atlantic cod, Gadus morhua L.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

The common mucosal immune system and current strategies for induction of immune responses in external secretions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

The mucosal immune system: from fundamental concepts to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Mucosal immunity to infection with implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Oral vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Recent advances in mucosal vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Expression of a foreign epitope on infectious pancreatic necrosis virus VP2 capsid protein subviral particle (SVP) and immunogenicity in rainbow trout.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Immunogenic and protective effects of an oral DNA vaccine against infectious pancreatic necrosis virus in fish

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

In vitro and in vivo immune responses induced by a DNA vaccine encoding the VP2 gene of the infectious pancreatic necrosis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Antigenicity of infectious pancreatic necrosis virus VP2 subviral particles expressed in yeast

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Comparison of the immune responses induced by oral immunization of mice with Lactobacillus casei-expressing porcine parvovirus VP2 and VP2 fused to Escherichia coli heat-labile enterotoxin B subunit protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Surface-displayed porcine epidemic diarrhea viral (PEDV) antigens on lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Immunomodulatory and protective effect of probiotic Lactobacillus casei against Candida albicans infection in malnourished mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Oral immunoadjuvant activity of Lactobacillus casei subsp. casei in dextran-fed layer chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Construction of recombinant Lactobacillus casei efficiently surface displayed and secreted porcine parvovirus VP2 protein and comparison of the immune responses induced by oral immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Detection and quantitation of infectious pancreatic necrosis virus by real-time reverse transcriptase-polymerase chain reaction using lethal and non-lethal tissue sampling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Ileal and jejunal Peyer's patches play distinct roles in mucosal immunity of sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Lactobacilli as live vaccine delivery vectors: progress and prospects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Regulatory considerations for nucleic acid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Safety considerations for nucleic acid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.132

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.12.132

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45360524&oldid=2075828680"